MedCram cover image

Episode 81. Current COVID Risk Assessment: BA.2.86 Variant, Boosters, and More

MedCram

00:00

BA 2.86 variant: Risk assessment and impact on immunity

This chapter explores the BA 2.86 variant of COVID-19, discussing its risk assessment, genetic differences, and impact on immunity. It clarifies confusion regarding its infection capability in individuals with previous COVID-19 infection or vaccination. The chapter also examines the mutations present in the variant and the effectiveness of monoclonal antibodies against it.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app